ImmunoTEP for Patients With Medullary Thyroid Carcinoma.

Inclusion Criteria: * Histological diagnosis of CMT * Calcitonin\> 150 pg / ml * Complete treatment of the primary tumor * at least one detectable lesion more than 10 mm on conventional imaging: bone lesions can be taken into account if they extend outside of the bone and the party extra bone is measurable. * Age ≥ 18 years * Negative pregnancy test for women of childbearing age in the previous 2 days immuno-PET. Women of childbearing potential should use effective contraception take continuously for 3 months. * KPS ≥ 70 or ECOG 0-1 and life expectancy of at least 6 months * Absence of serious illness or co-morbidity assessed risk * Creatinine ≤ 2.5 normal * Absence of cancer treatment within 6 weeks prior to the immuno-PET * No history of cancer within 5 years, except skin cancer other than melanoma or carcinoma in situ of the cervix * Lack of anti-antibodies in patients who have previously received antibodies and hypersensitivity to antibody or protein * Informed consent signed * Social Insurance Exclusion Criteria: * Pregnancy or breastfeeding * Serious illness or co-morbidity assessed risk * History of cancer within 5 years, except skin cancer other than melanoma or carcinoma in situ of the cervix * Presence of anti-antibodies in patients who have previously received antibodies * Known hypersensitivity to antibody or protein * Need to establish a cancer treatment within 3 months of immuno-PET (before stock evaluation 3 months) * Inability intellectual sign consent * Patient protected by law